Skip to content
← Back to this collection

PUBLICATIONS · 20855843

Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2010 Oct 20
First author
Brada M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Brada M
      type
      Author
    2. name
      Stenning S
      type
      Author
    3. name
      Gabe R
      type
      Author
    4. name
      Thompson LC
      type
      Author
    5. name
      Levy D
      type
      Author
    6. name
      Rampling R
      type
      Author
    7. name
      Erridge S
      type
      Author
    8. name
      Saran F
      type
      Author
    9. name
      Gattamaneni R
      type
      Author
    10. name
      Hopkins K
      type
      Author
    11. name
      Beall S
      type
      Author
    12. name
      Collins VP
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Brada M
      type
      Author
    2. name
      Stenning S
      type
      Author
    3. name
      Gabe R
      type
      Author
    4. name
      Thompson LC
      type
      Author
    5. name
      Levy D
      type
      Author
    6. name
      Rampling R
      type
      Author
    7. name
      Erridge S
      type
      Author
    8. name
      Saran F
      type
      Author
    9. name
      Gattamaneni R
      type
      Author
    10. name
      Hopkins K
      type
      Author
    11. name
      Beall S
      type
      Author
    12. name
      Collins VP
      type
      Author
    bibliography ids
    1. nci-bib-d4b03b4bed6172e54ba5c27b
    book metadata
    content sha256
    fff98f39547ba5afc3697e308dac73ecbaecbf294fbac6c0db3143ac65184eea
    document type
    citation
    dois
    1. 10.1200/JCO.2009.27.1932
    electronic publication date
    display
    2010 Sep 20
    precision
    day
    year
    2010
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:20855843
    immutable id
    pubmed:20855843@fff98f39547ba5afc3697e308dac73ecbaecbf294fbac6c0db3143ac65184eea
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    30
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    4601-8
    volume
    28
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      20855843
      provenance
      batch id
      10a38257e12e9ed1867a
      provider
      NCBI PubMed ESummary
      record sha256
      d6ff6d839da24f07d8e417293c159e9f441f11ef93130c3848aa200a4f074800
      response sha256
      84c4808ca38b35d999cfdf809eb088835175ab38d71586c626096d677096bbcc
      retrieved at
      2026-09-09T23:46:35.793530+00:00
      publication date
      display
      2010 Oct 20
      precision
      day
      year
      2010
      publication types
      1. Comparative Study
      2. Journal Article
      3. Multicenter Study
      4. Randomized Controlled Trial
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/20855843/
      title
      Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma.

      Preserved source evidence · Not medical advice